Table 2.

Correlation of Initial Serum Level of Mouse Anti-BCL1 Id to Development of Dormancy After BCL1 Challenge

Serum Anti-BCL1 Id (average μg/mL ± SD)Time of Onset of Splenomegaly (average day ± SD)
Nondormant animals (N = 15) 70 ± 57 36 ± 15 
Dormant animals (N = 28) 358 ± 546  —  
Subpopulation of dormant animals followed for splenomegaly (N = 11) 269 ± 189 132 ± 74 
Serum Anti-BCL1 Id (average μg/mL ± SD)Time of Onset of Splenomegaly (average day ± SD)
Nondormant animals (N = 15) 70 ± 57 36 ± 15 
Dormant animals (N = 28) 358 ± 546  —  
Subpopulation of dormant animals followed for splenomegaly (N = 11) 269 ± 189 132 ± 74 

Forty-three Id-immune animals were bled on day 0, and levels of α Id were determined. BCL1 cells (106) were then injected and the animals were followed for onset of splenomegaly. The differences in average initial serum levels of animals that became dormant versus animals that did not were statistically significant as measured by both the Mann-Whitney U-test (P = .03) and by t-test (P = .02). Because of the necessity of killing dormant animals for analysis, only a subpopulation of dormant animals were followed for the onset of splenomegaly. The average day to splenomegaly for the dormant mice is statistically different by t-test from the average day to splenomegaly for the nondormant animal group (P = .00004). The initial levels of mouse anti-BCL1 Id are also different for these two groups (P = .0008). Serum levels of total anti-BCL1Id IgG were measured by radioimmunoassay as previously described.11 

Close Modal

or Create an Account

Close Modal
Close Modal